TD Cowen lowered the firm’s price target on Bruker to $72 from $74 and keeps a Hold rating on the shares. The firm said 2Q organic and 2024 organic guide reamined, and after weak stock returns, the set up is arguably better.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: